Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
NCT01862536
Cardiovascular Diseases, Chronic Disease
West Los Angeles, California, United States
View Trial DetailsNCT Number: NCT07102823
Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension
Interested in participating?
Request Info18 year and older
All sexes
Observational
Medical University of Graz, Graz, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at inclusion
pulmonary vascular resistance > 5 WU (Wood Units)
Time frame: Until 2026
all-cause mortality
Medical University of Graz
Other
Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis
Acronym: COPD-PH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01862536
Cardiovascular Diseases, Chronic Disease
West Los Angeles, California, United States
View Trial DetailsNCT01615484
Alpha-1 Antitrypsin Deficiency, Bronchial Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06376994
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Birmingham, Alabama, United States
View Trial DetailsNCT07288554
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Hefei, Anhui, China
View Trial Details